Home » Newsletters » BioWorld Science

BioWorld Science

March 27, 2013

View Archived Issues

Small-molecule antiviral agents target HIV-1 replication

AstraZeneca and Moderna Therapeutics to develop messenger RNA therapeutics

Bluebird bio enters collaboration with Celgene

H3 Biomedicine and BGI to develop and share cancer genomic sequencing data

Benefits demonstrated for onabotulinumtoxinA in patients with OAB

Novel QC inhibitor shows promise as AD therapy in a phase I trial

BioCryst Pharmaceuticals patents new tyrosine-protein kinase inhibitors

Acofide tablets approved in Japan for functional dyspepsia

Auxilium announces topline data from study of Xiaflex in frozen shoulder syndrome

TOP2A as an independent biomarker of NPC tumor aggressiveness

Inovelon approved in Japan for Lennox-Gastaut syndrome

Neuropore Therapeutics presents novel therapeutic candidate for neurological disorders

arGEN-X advances ARGX-112 into preclinical development

New agents for substance abuse and dependence divulged by Gilead Sciences

Shionogi receives approval for metreleptin in Japan

Shin Nippon Biomedical and Nagasaki University enter collaboration

Reversible covalent modification of KEAP1 as a promising approach for PD therapy

Onglyza approved in Japan for type 2 diabetes

BioCryst commences clinical study of candidate for hereditary angioedema

Lundbeck and Otsuka expand collaboration to include Lu-AE-58054

Shire gains lifitegrast with acquisition of SARcode Bioscience

Chugai gains Japanese approval for subcutaneous formulation of Actemra

Japanese authorities approve denosumab for osteoporosis

FDA approves botulism antitoxin manufactured by Cangene

GSK gives update on FDA's review of H5N1 adjuvanted influenza vaccine

Eisai set to launch neuromuscular-blocking agent in Japan for cervical dystonia

Bristol-Myers Squibb presents new series of anti-HIV agents

FDA approves Novartis' dry powder inhaled antibacterial Tobi Podhaler

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...